Dr. Wendell P. Davis Joins Altasciences as Vice President, Pathology
Laval, Quebec, February 7, 2022 – Altasciences announced today the appointment of Dr. Wendell P. Davis, D.V.M., Dipl. ACVP, as Vice President, Pathology, effective February 7, 2022.
Dr. Davis is a nonclinical development professional with extensive experience in toxicologic pathology and a proven track record of building and leading high functioning pathology groups in both the biotechnology and CRO sectors. He is a proven leader with a passion for building pathology capabilities and mentoring pathologists, research, and laboratory scientists.
As a study pathologist and peer reviewer, he has experience evaluating small molecules, biologics, oligonucleotide, and an array of RNA therapeutics modalities across a range of preclinical species and routes of administration, in support of both early candidate selection and regulatory filings.
Dr. Davis has also maintained an active role in the industry as a member of the Society of Toxicologic Pathology and as a diplomat member of the American College of Veterinary Pathologists.
“Wendell’s track record and leadership experience in the fields of anatomical pathology, discovery toxicology, and toxicologic pathology, as well as his ability to mitigate challenging toxicologic pathology issues will make him a great addition to our team, and deliver expert guidance for our clients,” said Mike Broadhurst, General Manager, Preclinical Services, at Altasciences.
Altasciences has strategically located preclinical research facilities in Seattle, Scranton, and Columbia, U.S.A. With over 25 years of experience conducting safety assessment, Altasciences offers a full range of in vivo GLP and non-GLP preclinical studies in multiple species to thoroughly assess the safety profile of molecules.
About Altasciences
Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.
CONTACT:
Julie-Ann Cabana
Altasciences
514 601-9763
jcabana@altasciences.com
ghp Technology Awards 2021: Altasciences Named Best Pharmaceutical & Biotechnology Research Organisation 2021
How to Maximize Drug Development Success of Biologics
Combining Trial Conduct and Bioanalysis for Success
Combining Phase I trial conduct of biologics and bioanalysis is critical for successful drug development. Clinical development relies heavily on bioanalytical experts to generate critical data to understand pharmacokinetics and pharmacodynamics.
Here are just some of the benefits of working with Altasciences:
- Timed interim sample analysis for dose escalation decisions
- Rapid turnaround of PK/PD analysis between cohorts
- Biomarker development and validation for exploratory or primary endpoints
- Proximity flow cytometry
- Centralized scheduling between clinic and lab
- Ability to easily switch or combine platforms which are sensitive, have high throughput, and demonstrate exquisite specificity
Watch this complimentary webinar to see how you can overcome challenges throughout all phases of drug development.
Have 5 minutes? Take a look at these:
- How Is Partnering with Altasciences for Your First-in-Human Clinical Trials Different?
- Microsampling in Drug Development
- Validated Bioanalytical Assay List
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Experts in Complex and Customized Formulations
Over 80% of drugs will fail during clinical development due to formulation challenges. Having developed, tested, and manufactured almost every type of dosage form on the market, Altasciences has the expertise to customize our services to your API’s needs, taking it through its entire lifecycle and ensuring its successful delivery ― from prototype formulation development, to scale-up and ICH stability, to clinical manufacturing and commercial supply.
Our scientists tailor your drug compound to ensure optimal solubility and bioavailability. In addition, we have extensive experience handling complex and highly potent products. Finally, our state-of the art technology and banding equipment make us leaders in the development of hard-shell, liquid-filled capsules ― a dosage form often required for poorly soluble, highly potent or low dose APIs.
Partner with us today to reduce your development timelines and risk of product failure.
You may also be interested in the following:
NEW PODCAST — Sample Collection Kits and Lab Manual Services
Sample Management Based on Your Specific Needs
Did you know that Altasciences’ Material Management Team has over 25 years of experience? Indeed, our experts in sample management processes have been supporting clinical trials worldwide for over two decades.
We have designed an efficient system for accurate and safe clinical sample preparation, collection, and shipment from trial sites to bioanalytical laboratories.
Watch to learn more.
Questions about our customized offering? Send us a message.
You may also be interested in:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Outsourcing your Clinical Site Management and Monitoring
Multi-Site Clinical Trial Management and Monitoring
With extensive expertise in a wide range of study types and therapeutic areas, Altasciences’ clinical monitoring and site management teams deliver reliable data, fast. Our experts work closely with you and your sites, to guide you through the complex steps of drug development.
Clinical Monitoring:
Highly skilled clinical research associates oversee all aspects of your clinical trial conduct to ensure data integrity, patient safety, protocol compliance, and GCP.
Site Management:
Experienced project managers oversee the conduct of multi-site programs in close collaboration with key internal and external stakeholders, ensuring seamless and timely communication.
Whether as stand-alone or part of an integrated program, let’s discuss your clinical monitoring and site management requirements today.
Have 5 minutes? You may be interested in:
- Impaired Renal and Hepatic Function Trials Capabilities
- Full-Time Equivalent Capabilities
- Research Support Services Capabilities
- Integrated Drug Development Services
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Looking to Outsource Your Drug Development and Manufacturing?
Your Drug Development and Manufacturing Partner ― Altasciences at a Glance
Altasciences can support your drug formulation, development, and manufacturing needs, from formulation through to commercialization.
We excel in the full range of drug development and manufacturing solutions, including:
- Handling complex formulations and highly potent compounds (HPAPIs)
- Custom formulation development
- Manufacturing of liquid-filled, hard-shell capsules
- Nanomilling – to resolve solubility and bioavailability challenges
- Terminal sterilization
In addition, our integrated CRO/CDMO end-to-end solutions can reduce your drug development program timeline by up to 40% ― from discovery to preclinical to clinical proof of concept, and beyond.
Partner with us today.
Got a few more minutes?
See our full range of drug development and manufacturing solutions. | Take a tour of our manufacturing facility and analytical laboratories. |
Did you miss our webinar titled “The Development of Nanosuspension Formulations for Poorly Soluble Drugs”? View it ON-DEMAND!
Five General Knowledge Questions That You Probably Don’t Know the Answer To
They say a good scientist requires curiosity, first and foremost. When we are not hard at work, Altascientists (as we like to call ourselves) spend a lot of time questioning things that make you go hmm.
Here are a few examples…
Not Your Average CRO/CDMO
Our Commitment to You
Your new drug could be the one that changes someone’s life. As investors in life sciences, we know that each project matters. Whether you place one study or multiple programs with us, we treat each project with the equal care and dedication it deserves, no matter the size or spend.
We are committed to making your project a success. After all, your success is our success. And our success, together, means getting better drugs to people who need them, faster.
Speak with an Altasciences expert today.
TAKE FIVE:
- Watch this video to experience the difference
- Check out our new interactive brochure
- Discover our Proactive Drug Development approach
- Read this blog article: Five Ways Altasciences Simplifies the Drug Development Process for You
- Catch up on our top scientific resources of 2021
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.